aluates Reports

$ 0.0

Automative

Global Ischemia Reperfusion Injury Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-24W632

Global Ischemia Reperfusion Injury Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Ischemia Reperfusion Injury Market Research Report 2024

Code: QYRE-Auto-24W632

Report

February 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Angion Biomedica

Catalyst Biosciences

Ischemix Inc

Opsona Therapeutics

Pharming

TheraSource

Bolder Biotechnology

Corline Biomedical

Mifcortx

Balmes Transplantation

NovelMed Therapeutics

Hope Pharmaceuticals

Omeros Corp

Prothix

SBI Pharmaceuticals

Ischemia Reperfusion Injury Market

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

The global Ischemia Reperfusion Injury market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.

North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.

In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.

This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury.

Report Scope

The Ischemia Reperfusion Injury market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ischemia Reperfusion Injury market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ischemia Reperfusion Injury companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ischemia Reperfusion Injury Market Report

Report Metric	Details
Report Name	Ischemia Reperfusion Injury Market
Segment by Type	Phase 1 Phase 2 Preclinical
Segment by Application	Heart Injury Kidney Injury Intestine Injury Other Injury
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical, Mifcortx, Balmes Transplantation, NovelMed Therapeutics, Hope Pharmaceuticals, Omeros Corp, Prothix, SBI Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ischemia Reperfusion Injury companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Ischemia Reperfusion Injury Market share by type?

Ans: In terms of product, Phase 2 is the largest segment, with a share about 40%.

Who are the main players in the Ischemia Reperfusion Injury Market report?

Ans: The main players in the Ischemia Reperfusion Injury Market are Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical, Mifcortx, Balmes Transplantation, NovelMed Therapeutics, Hope Pharmaceuticals, Omeros Corp, Prothix, SBI Pharmaceuticals

What are the Application segmentation covered in the Ischemia Reperfusion Injury Market report?

Ans: The Applications covered in the Ischemia Reperfusion Injury Market report are Heart Injury, Kidney Injury, Intestine Injury, Other Injury

What are the Type segmentation covered in the Ischemia Reperfusion Injury Market report?

Ans: The Types covered in the Ischemia Reperfusion Injury Market report are Phase 1, Phase 2, Preclinical

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Phase 1

1.2.3 Phase 2

1.2.4 Preclinical

1.3 Market by Application

1.3.1 Global Ischemia Reperfusion Injury Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Heart Injury

1.3.3 Kidney Injury

1.3.4 Intestine Injury

1.3.5 Other Injury

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ischemia Reperfusion Injury Market Perspective (2019-2030)

2.2 Ischemia Reperfusion Injury Growth Trends by Region

2.2.1 Global Ischemia Reperfusion Injury Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Ischemia Reperfusion Injury Historic Market Size by Region (2019-2024)

2.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030)

2.3 Ischemia Reperfusion Injury Market Dynamics

2.3.1 Ischemia Reperfusion Injury Industry Trends

2.3.2 Ischemia Reperfusion Injury Market Drivers

2.3.3 Ischemia Reperfusion Injury Market Challenges

2.3.4 Ischemia Reperfusion Injury Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ischemia Reperfusion Injury Players by Revenue

3.1.1 Global Top Ischemia Reperfusion Injury Players by Revenue (2019-2024)

3.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2019-2024)

3.2 Global Ischemia Reperfusion Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Ischemia Reperfusion Injury Revenue

3.4 Global Ischemia Reperfusion Injury Market Concentration Ratio

3.4.1 Global Ischemia Reperfusion Injury Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ischemia Reperfusion Injury Revenue in 2023

3.5 Ischemia Reperfusion Injury Key Players Head office and Area Served

3.6 Key Players Ischemia Reperfusion Injury Product Solution and Service

3.7 Date of Enter into Ischemia Reperfusion Injury Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Ischemia Reperfusion Injury Breakdown Data by Type

4.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2019-2024)

4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030)

5 Ischemia Reperfusion Injury Breakdown Data by Application

5.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2019-2024)

5.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Ischemia Reperfusion Injury Market Size (2019-2030)

6.2 North America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Ischemia Reperfusion Injury Market Size by Country (2019-2024)

6.4 North America Ischemia Reperfusion Injury Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ischemia Reperfusion Injury Market Size (2019-2030)

7.2 Europe Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024)

7.4 Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ischemia Reperfusion Injury Market Size (2019-2030)

8.2 Asia-Pacific Ischemia Reperfusion Injury Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2019-2024)

8.4 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ischemia Reperfusion Injury Market Size (2019-2030)

9.2 Latin America Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024)

9.4 Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ischemia Reperfusion Injury Market Size (2019-2030)

10.2 Middle East & Africa Ischemia Reperfusion Injury Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2019-2024)

10.4 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Angion Biomedica

11.1.1 Angion Biomedica Company Detail

11.1.2 Angion Biomedica Business Overview

11.1.3 Angion Biomedica Ischemia Reperfusion Injury Introduction

11.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.1.5 Angion Biomedica Recent Development

11.2 Catalyst Biosciences

11.2.1 Catalyst Biosciences Company Detail

11.2.2 Catalyst Biosciences Business Overview

11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Introduction

11.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.2.5 Catalyst Biosciences Recent Development

11.3 Ischemix Inc

11.3.1 Ischemix Inc Company Detail

11.3.2 Ischemix Inc Business Overview

11.3.3 Ischemix Inc Ischemia Reperfusion Injury Introduction

11.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.3.5 Ischemix Inc Recent Development

11.4 Opsona Therapeutics

11.4.1 Opsona Therapeutics Company Detail

11.4.2 Opsona Therapeutics Business Overview

11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Introduction

11.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.4.5 Opsona Therapeutics Recent Development

11.5 Pharming

11.5.1 Pharming Company Detail

11.5.2 Pharming Business Overview

11.5.3 Pharming Ischemia Reperfusion Injury Introduction

11.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.5.5 Pharming Recent Development

11.6 TheraSource

11.6.1 TheraSource Company Detail

11.6.2 TheraSource Business Overview

11.6.3 TheraSource Ischemia Reperfusion Injury Introduction

11.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.6.5 TheraSource Recent Development

11.7 Bolder Biotechnology

11.7.1 Bolder Biotechnology Company Detail

11.7.2 Bolder Biotechnology Business Overview

11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Introduction

11.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.7.5 Bolder Biotechnology Recent Development

11.8 Corline Biomedical

11.8.1 Corline Biomedical Company Detail

11.8.2 Corline Biomedical Business Overview

11.8.3 Corline Biomedical Ischemia Reperfusion Injury Introduction

11.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.8.5 Corline Biomedical Recent Development

11.9 Mifcortx

11.9.1 Mifcortx Company Detail

11.9.2 Mifcortx Business Overview

11.9.3 Mifcortx Ischemia Reperfusion Injury Introduction

11.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.9.5 Mifcortx Recent Development

11.10 Balmes Transplantation

11.10.1 Balmes Transplantation Company Detail

11.10.2 Balmes Transplantation Business Overview

11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Introduction

11.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.10.5 Balmes Transplantation Recent Development

11.11 NovelMed Therapeutics

11.11.1 NovelMed Therapeutics Company Detail

11.11.2 NovelMed Therapeutics Business Overview

11.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Introduction

11.11.4 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.11.5 NovelMed Therapeutics Recent Development

11.12 Hope Pharmaceuticals

11.12.1 Hope Pharmaceuticals Company Detail

11.12.2 Hope Pharmaceuticals Business Overview

11.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Introduction

11.12.4 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.12.5 Hope Pharmaceuticals Recent Development

11.13 Omeros Corp

11.13.1 Omeros Corp Company Detail

11.13.2 Omeros Corp Business Overview

11.13.3 Omeros Corp Ischemia Reperfusion Injury Introduction

11.13.4 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.13.5 Omeros Corp Recent Development

11.14 Prothix

11.14.1 Prothix Company Detail

11.14.2 Prothix Business Overview

11.14.3 Prothix Ischemia Reperfusion Injury Introduction

11.14.4 Prothix Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.14.5 Prothix Recent Development

11.15 SBI Pharmaceuticals

11.15.1 SBI Pharmaceuticals Company Detail

11.15.2 SBI Pharmaceuticals Business Overview

11.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Introduction

11.15.4 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024)

11.15.5 SBI Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Angion Biomedica

Catalyst Biosciences

Ischemix Inc

Opsona Therapeutics

Pharming

TheraSource

Bolder Biotechnology

Corline Biomedical

Mifcortx

Balmes Transplantation

NovelMed Therapeutics

Hope Pharmaceuticals

Omeros Corp

Prothix

SBI Pharmaceuticals

List of Tables

Table 1. Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Phase 1

Table 3. Key Players of Phase 2

Table 4. Key Players of Preclinical

Table 5. Global Ischemia Reperfusion Injury Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Ischemia Reperfusion Injury Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Ischemia Reperfusion Injury Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Ischemia Reperfusion Injury Market Share by Region (2019-2024)

Table 9. Global Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Ischemia Reperfusion Injury Market Share by Region (2025-2030)

Table 11. Ischemia Reperfusion Injury Market Trends

Table 12. Ischemia Reperfusion Injury Market Drivers

Table 13. Ischemia Reperfusion Injury Market Challenges

Table 14. Ischemia Reperfusion Injury Market Restraints

Table 15. Global Ischemia Reperfusion Injury Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Ischemia Reperfusion Injury Market Share by Players (2019-2024)

Table 17. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury as of 2023)

Table 18. Ranking of Global Top Ischemia Reperfusion Injury Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Ischemia Reperfusion Injury Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Ischemia Reperfusion Injury Product Solution and Service

Table 22. Date of Enter into Ischemia Reperfusion Injury Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Ischemia Reperfusion Injury Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2019-2024)

Table 26. Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2025-2030)

Table 28. Global Ischemia Reperfusion Injury Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2019-2024)

Table 30. Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2025-2030)

Table 32. North America Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Ischemia Reperfusion Injury Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Ischemia Reperfusion Injury Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2025-2030) & (US$ Million)

Table 47. Angion Biomedica Company Detail

Table 48. Angion Biomedica Business Overview

Table 49. Angion Biomedica Ischemia Reperfusion Injury Product

Table 50. Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 51. Angion Biomedica Recent Development

Table 52. Catalyst Biosciences Company Detail

Table 53. Catalyst Biosciences Business Overview

Table 54. Catalyst Biosciences Ischemia Reperfusion Injury Product

Table 55. Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 56. Catalyst Biosciences Recent Development

Table 57. Ischemix Inc Company Detail

Table 58. Ischemix Inc Business Overview

Table 59. Ischemix Inc Ischemia Reperfusion Injury Product

Table 60. Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 61. Ischemix Inc Recent Development

Table 62. Opsona Therapeutics Company Detail

Table 63. Opsona Therapeutics Business Overview

Table 64. Opsona Therapeutics Ischemia Reperfusion Injury Product

Table 65. Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 66. Opsona Therapeutics Recent Development

Table 67. Pharming Company Detail

Table 68. Pharming Business Overview

Table 69. Pharming Ischemia Reperfusion Injury Product

Table 70. Pharming Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 71. Pharming Recent Development

Table 72. TheraSource Company Detail

Table 73. TheraSource Business Overview

Table 74. TheraSource Ischemia Reperfusion Injury Product

Table 75. TheraSource Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 76. TheraSource Recent Development

Table 77. Bolder Biotechnology Company Detail

Table 78. Bolder Biotechnology Business Overview

Table 79. Bolder Biotechnology Ischemia Reperfusion Injury Product

Table 80. Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 81. Bolder Biotechnology Recent Development

Table 82. Corline Biomedical Company Detail

Table 83. Corline Biomedical Business Overview

Table 84. Corline Biomedical Ischemia Reperfusion Injury Product

Table 85. Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 86. Corline Biomedical Recent Development

Table 87. Mifcortx Company Detail

Table 88. Mifcortx Business Overview

Table 89. Mifcortx Ischemia Reperfusion Injury Product

Table 90. Mifcortx Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 91. Mifcortx Recent Development

Table 92. Balmes Transplantation Company Detail

Table 93. Balmes Transplantation Business Overview

Table 94. Balmes Transplantation Ischemia Reperfusion Injury Product

Table 95. Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 96. Balmes Transplantation Recent Development

Table 97. NovelMed Therapeutics Company Detail

Table 98. NovelMed Therapeutics Business Overview

Table 99. NovelMed Therapeutics Ischemia Reperfusion Injury Product

Table 100. NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 101. NovelMed Therapeutics Recent Development

Table 102. Hope Pharmaceuticals Company Detail

Table 103. Hope Pharmaceuticals Business Overview

Table 104. Hope Pharmaceuticals Ischemia Reperfusion Injury Product

Table 105. Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 106. Hope Pharmaceuticals Recent Development

Table 107. Omeros Corp Company Detail

Table 108. Omeros Corp Business Overview

Table 109. Omeros Corp Ischemia Reperfusion Injury Product

Table 110. Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 111. Omeros Corp Recent Development

Table 112. Prothix Company Detail

Table 113. Prothix Business Overview

Table 114. Prothix Ischemia Reperfusion Injury Product

Table 115. Prothix Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 116. Prothix Recent Development

Table 117. SBI Pharmaceuticals Company Detail

Table 118. SBI Pharmaceuticals Business Overview

Table 119. SBI Pharmaceuticals Ischemia Reperfusion Injury Product

Table 120. SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024) & (US$ Million)

Table 121. SBI Pharmaceuticals Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Ischemia Reperfusion Injury Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Ischemia Reperfusion Injury Market Share by Type: 2023 VS 2030

Figure 3. Phase 1 Features

Figure 4. Phase 2 Features

Figure 5. Preclinical Features

Figure 6. Global Ischemia Reperfusion Injury Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Ischemia Reperfusion Injury Market Share by Application: 2023 VS 2030

Figure 8. Heart Injury Case Studies

Figure 9. Kidney Injury Case Studies

Figure 10. Intestine Injury Case Studies

Figure 11. Other Injury Case Studies

Figure 12. Ischemia Reperfusion Injury Report Years Considered

Figure 13. Global Ischemia Reperfusion Injury Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Ischemia Reperfusion Injury Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Ischemia Reperfusion Injury Market Share by Region: 2023 VS 2030

Figure 16. Global Ischemia Reperfusion Injury Market Share by Players in 2023

Figure 17. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Ischemia Reperfusion Injury Revenue in 2023

Figure 19. North America Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Ischemia Reperfusion Injury Market Share by Country (2019-2030)

Figure 21. United States Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Ischemia Reperfusion Injury Market Share by Country (2019-2030)

Figure 25. Germany Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Ischemia Reperfusion Injury Market Share by Region (2019-2030)

Figure 33. China Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Ischemia Reperfusion Injury Market Share by Country (2019-2030)

Figure 41. Mexico Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2019-2030)

Figure 45. Turkey Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Ischemia Reperfusion Injury Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Angion Biomedica Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 48. Catalyst Biosciences Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 49. Ischemix Inc Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 50. Opsona Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 51. Pharming Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 52. TheraSource Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 53. Bolder Biotechnology Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 54. Corline Biomedical Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 55. Mifcortx Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 56. Balmes Transplantation Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 57. NovelMed Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 58. Hope Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 59. Omeros Corp Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 60. Prothix Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 61. SBI Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions